March 3, 2022
The MMA’s next noon-time forum, which will discuss harm reduction approaches to reducing drug use, takes place March 8 from noon to 1 p.m.
The forum will include the following experts:
Heather Bell, MD, FASAM, FAAFP, Addiction Services and Primary Care, CentraCare
Ryan Kelly, MD, MS, Internal Medicine, Pediatrics, Harm Reduction Addiction, Community-University Health Care Center at the University of Minnesota, SouthSide Harm Reduction
Sheila P. Vakharia PhD LMSW, Deputy Director, Department of Research and Academic Engagement, Drug Policy Alliance
Learning objectives for the forum include:
Explore harm reduction approaches to reducing drug use.
Describe the harm reduction approaches currently being used in Minnesota.
Identify policies needed to lessen the personal and public health impacts of behavior associated with alcohol and other substance use.
To register, click here.
The forum is free to members, $15 for non-members. This forum is being sponsored by AstraZeneca and COPIC.
April 9, 2026
An amended piece of legislation that would exempt buprenorphine from prior authorization (PA) was heard in the Senate Health and Human Services Committee on April 9.
April 9, 2026
On April 9, the Senate Health and Human Services Committee heard a bill that would require coverage for psychiatric Collaborative Care Model (CoCM) services under Medical Assistance.
April 9, 2026
On April 9, the House Taxes Committee heard legislation focused on supporting the financial stability and ongoing operations of Hennepin Healthcare.